Equity in HTA: what doesn’t get measured, gets marginalised
Abstract When making recommendations about the public funding of new health technologies, policy makers typically pay close attention to quantitative evidence about the comparative effectiveness, cost effectiveness and budget impact of those technologies – what we might call “efficiency” criteria. L...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2017-07-01
|
| Series: | Israel Journal of Health Policy Research |
| Online Access: | http://link.springer.com/article/10.1186/s13584-017-0162-3 |